|
|
||||||||
AJP - Renal Physiology, Vol 266, Issue 2 227-F239, Copyright © 1994 by American Physiological Society
ARTICLES |
H. Weihprecht, J. N. Lorenz, J. P. Briggs and J. Schnermann
Department of Physiology, University of Michigan, Ann Arbor 48104.
Experiments were performed in the in situ kidney of rats and in isolated afferent arterioles of the rabbit to study the interaction between angiotensin II and adenosine in producing afferent arteriolar vasoconstriction. In the intact rat kidney, we observed that 1) peritubular infusion of the adenosine1-receptor blocker 8-cyclopentyl-1,3-dipropylxanthine (CPX, 10(-4) M) blocked the fall in stop-flow pressure (PSF) induced by angiotensin II (5 x 10(-7) M) but not that caused by vasopressin (10(-5) M) or norepinephrine (10(-5) M), 2) peritubular infusion of saralasin (5 x 10(-5) M) attenuated the fall in PSF caused by N6-cyclohexyladenosine (CHA, 10(-5) M) 3) the fall in PSF following luminal application of CHA (10(-5) M) was reduced in angiotensin II-depleted states (volume expansion and converting enzyme inhibition) and this could be reversed by infusion of low doses of angiotensin II, and 4) the reduction in PSF in response to luminal infusion of CHA was augmented in a greater-than-additive fashion when angiotensin was simultaneously administered at low intravenous infusion rates. In isolated afferent arterioles of the rabbit, we noted that 1) addition of 10(-5) M CPX to the bath significantly blunted the constrictor effect of angiotensin II (10(-8) M), 2) presence of the converting enzyme inhibitor quinaprilate (10(-7) M) caused a right shift in the constrictor-response curve to increasing concentrations of CHA (10(-9)-10(-5) M) but 10(-5) M saralasin did not affect vasoconstriction caused by 10(-6) M adenosine, 3) simultaneous administration of submaximal constrictor doses of angiotensin II (10(-10) M) and adenosine (10(-6) M) produced vasoconstriction that was greater than additive, and 4) 10(-5) M CHA and angiotensin II (10(-7) M) constricted afferent arterioles after removal of the glomerulus, whereas either agent alone had no constrictor effect in this preparation. Our results suggest that adenosine and angiotensin cooperate in a mutually dependent and synergistic fashion in producing afferent arteriolar vasoconstriction.
This article has been cited by other articles:
![]() |
M. Carlstrom, E. Y. Lai, Z. Ma, A. Patzak, R. D. Brown, and A. E. G. Persson Role of NOX2 in the regulation of afferent arteriole responsiveness Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2009; 296(1): R72 - R79. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Franco, R. Bautista, O. Perez-Mendez, L. Gonzalez, U. Pacheco, L. G. Sanchez-Lozada, J. Santamaria, E. Tapia, R. Monreal, and F. Martinez Renal interstitial adenosine is increased in angiotensin II-induced hypertensive rats Am J Physiol Renal Physiol, January 1, 2008; 294(1): F84 - F92. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Patzak, E. Y. Lai, M. Fahling, M. Sendeski, P. Martinka, P. B. Persson, and A. E. G. Persson Adenosine enhances long term the contractile response to angiotensin II in afferent arterioles Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2007; 293(6): R2232 - R2242. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Y. Huang, V. Vallon, H. Zimmermann, P. Koszalka, J. Schrader, and H. Osswald Ecto-5'-nucleotidase (cd73)-dependent and -independent generation of adenosine participates in the mediation of tubuloglomerular feedback in vivo Am J Physiol Renal Physiol, August 1, 2006; 291(2): F282 - F288. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Vallon, B. Muhlbauer, and H. Osswald Adenosine and kidney function. Physiol Rev, July 1, 2006; 86(3): 901 - 940. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Hansen and J. Schnermann Vasoconstrictor and vasodilator effects of adenosine in the kidney Am J Physiol Renal Physiol, October 1, 2003; 285(4): F590 - F599. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. W. Inscho Modulation of renal microvascular function by adenosine Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2003; 285(1): R23 - R25. [Full Text] [PDF] |
||||
![]() |
P. B. Hansen, S. Hashimoto, J. Briggs, and J. Schnermann Attenuated renovascular constrictor responses to angiotensin II in adenosine 1 receptor knockout mice Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2003; 285(1): R44 - R49. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Schnermann The Juxtaglomerular Apparatus: From Anatomical Peculiarity to Physiological Relevance J. Am. Soc. Nephrol., June 1, 2003; 14(6): 1681 - 1694. [Full Text] [PDF] |
||||
![]() |
Y. Aki, A. Nishiyama, A. Miyatake, S. Kimura, M. Kohno, and Y. Abe Role of Adenosine A1 Receptor in Angiotensin II- and Norepinephrine-Induced Renal Vasoconstriction J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 117 - 123. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. Jackson, C. Zhu, and S. P. Tofovic Expression of adenosine receptors in the preglomerular microcirculation Am J Physiol Renal Physiol, July 1, 2002; 283(1): F41 - F51. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. Jackson and R. K. Dubey Role of the extracellular cAMP-adenosine pathway in renal physiology Am J Physiol Renal Physiol, October 1, 2001; 281(4): F597 - F612. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sun, L. C. Samuelson, T. Yang, Y. Huang, A. Paliege, T. Saunders, J. Briggs, and J. Schnermann Mediation of tubuloglomerular feedback by adenosine: Evidence from mice lacking adenosine 1 receptors PNAS, August 14, 2001; 98(17): 9983 - 9988. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. W. Inscho P2 receptors in regulation of renal microvascular function Am J Physiol Renal Physiol, June 1, 2001; 280(6): F927 - F944. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nishiyama, S. Kimura, H. He, K. Miura, M. Rahman, Y. Fujisawa, T. Fukui, and Y. Abe Renal interstitial adenosine metabolism during ischemia in dogs Am J Physiol Renal Physiol, February 1, 2001; 280(2): F231 - F238. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. K. Jackson and Z. Mi Preglomerular Microcirculation Expresses the cAMP-Adenosine Pathway J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 23 - 28. [Abstract] [Full Text] |
||||
![]() |
K. Brannstrom and W. J. Arendshorst Resetting of exaggerated tubuloglomerular feedback activity in acutely volume-expanded young SHR Am J Physiol Renal Physiol, March 1, 1999; 276(3): F409 - F416. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Traynor, T. Yang, Y. G. Huang, L. Arend, M. I. Oliverio, T. Coffman, J. P. Briggs, and J. Schnermann Inhibition of adenosine-1 receptor-mediated preglomerular vasoconstriction in AT1A receptor-deficient mice Am J Physiol Renal Physiol, December 1, 1998; 275(6): F922 - F927. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Schnermann Juxtaglomerular cell complex in the regulation of renal salt excretion Am J Physiol Regulatory Integrative Comp Physiol, February 1, 1998; 274(2): R263 - R279. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-P. Yip and D. J. Marsh An Arg-Gly-Asp peptide stimulates constriction in rat afferent arteriole Am J Physiol Renal Physiol, November 1, 1997; 273(5): F768 - F776. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ren, O. A. Carretero, and S. Ito Influence of NaCl Concentration at the Macula Densa on Angiotensin II–Induced Constriction of the Afferent Arteriole Hypertension, March 1, 1996; 27(3): 649 - 652. [Abstract] [Full Text] |
||||
![]() |
E. W. Inscho and A. K. Cook P2 receptor-mediated afferent arteriolar vasoconstriction during calcium blockade Am J Physiol Renal Physiol, February 1, 2002; 282(2): F245 - F255. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |